Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5188873
Max Phase: Preclinical
Molecular Formula: C58H82N8O13
Molecular Weight: 1099.34
Associated Items:
ID: ALA5188873
Max Phase: Preclinical
Molecular Formula: C58H82N8O13
Molecular Weight: 1099.34
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccc(OC(C)(C)C)cc1)C(=O)N1CCC[C@H]1C(=O)O
Standard InChI: InChI=1S/C58H82N8O13/c1-35(2)30-43(51(70)60-37(5)53(72)65(10)46(54(73)66-29-17-22-45(66)56(75)76)32-39-23-25-41(26-24-39)79-58(6,7)8)61-49(69)33-47(67)42(31-38-18-13-11-14-19-38)62-52(71)44(27-28-48(59)68)64(9)55(74)50(36(3)4)63-57(77)78-34-40-20-15-12-16-21-40/h11-16,18-21,23-26,35-37,42-47,50,67H,17,22,27-34H2,1-10H3,(H2,59,68)(H,60,70)(H,61,69)(H,62,71)(H,63,77)(H,75,76)/t37-,42-,43-,44-,45-,46+,47-,50-/m0/s1
Standard InChI Key: DASHUKGLLYFZSN-TXINUMBWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1099.34 | Molecular Weight (Monoisotopic): 1098.6001 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Li Z, Li H, Jiang F, Wang Z, Zhang W.. (2022) Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability., 57 [PMID:35121401] [10.1016/j.bmc.2022.116646] |
Source(1):